Skip to main content
Clinical Trials/IRCT20140911019125N11
IRCT20140911019125N11RecruitingPhase 1

Investigating the effect of intravenous injection of deciduous tooth pulp mesenchymal stem cells in patients with uncompensated liver cirrhosis in order to reduce the complications of the disease

Kerman University of Medical Sciences0 sites10 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Having clinical and laboratory manifestations related to uncompensated liver cirrhosis
  • Age between 18 and 65 years
  • Absence of pregnancy in women
  • There is no specific treatment for cirrhosis
  • Consent to participate in the study

Exclusion Criteria

  • Having an underlying malignancy
  • Evidence of extrahepatic biliary diseases
  • Active thrombosis in the hepatic or portal vein
  • Respiratory or kidney failure
  • Active infection
  • Liver transplantion candidate patients
  • Patients with diabetes mellitus
  • Patients with severe cardiovascular disease and high blood pressure not controlled by medication
  • The presence of severe underlying diseases
  • pregnant women

Investigators

Similar Trials